glp-1 makers Insulin pump-makers grapple with questions about GLP-1s Insulin, GLP-1 makers to face

References Centers for Medicare & Medicaid Services (CMS)

Novo Nordisk, the manufacturer of the Wegovy pill, explains that one of the main barriers to creating an effective GLP-1 pill was finding a way for the drug to survive the digestive process

Lifestyle counts: Even though its easier to take, patients will still need healthy eating, exercise, and follow-up labs to get the most out of treatment

Currently there is no evidence that it causes medullary thyroid cancer or affects MEN2 in humans ( Exp Diabetes Res

These concerns are not theoretical

Evidence suggests that rapid and substantial weight loss, rather than the medication alone, drives most hepatobiliary events